176 related articles for article (PubMed ID: 35406415)
1. The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes.
Meldolesi E; Chiloiro G; Giannini R; Menghi R; Persiani R; Corvari B; Coco C; Manfrida S; Ratto C; De Luca V; Sofo L; Reina S; Crucitti A; Masiello V; Dinapoli N; Valentini V; Gambacorta MA
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406415
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results of simultaneous integrated boost intensity-modulated radiation therapy based neoadjuvant chemoradiotherapy on locally advanced rectal cancer with clinically suspected positive lateral pelvic lymph nodes.
Geng JH; Zhang YZ; Li YH; Li S; Wang L; Wang ZL; Zhu XG; Bu ZD; Li ZY; Su XQ; Cai Y; Wu AW; Wang WH
Ann Transl Med; 2021 Feb; 9(3):217. PubMed ID: 33708844
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph Node.
Li S; Zhang Y; Yu Y; Zhu X; Geng J; Teng H; Wang Z; Sun T; Wang L; Wang H; Li Y; Wu A; Cai Y; Wang W
Front Oncol; 2020; 10():627572. PubMed ID: 33692945
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study.
Lupattelli M; Palazzari E; Polesel J; Chiloiro G; Angelicone I; Panni V; Caravatta L; Di Biase S; Macchia G; Niespolo RM; Franco P; Epifani V; Meldolesi E; de Giacomo F; Lucarelli M; Montesi G; Mantello G; Innocente R; Osti MF; Gambacorta MA; Aristei C; De Paoli A
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067405
[TBL] [Abstract][Full Text] [Related]
5. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
6. Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West?
Otero de Pablos J; Mayol J
Front Surg; 2019; 6():79. PubMed ID: 32010707
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
[TBL] [Abstract][Full Text] [Related]
8. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of enlarged lateral pelvic lymph nodes before and after preoperative chemoradiotherapy for rectal cancer.
Inoue Y; Saigusa S; Hiro J; Toiyama Y; Araki T; Tanaka K; Mohri Y; Kusunoki M
Mol Clin Oncol; 2016 Jun; 4(6):994-1002. PubMed ID: 27313860
[TBL] [Abstract][Full Text] [Related]
10. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous integrated or sequential boost to clinically involved lymph nodes in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy.
Kahvecioglu A; Gurlek E; Yedekci FY; Sari SY; Gultekin M; Yildiz F
Gynecol Oncol; 2023 Sep; 176():10-15. PubMed ID: 37413947
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic significance of D3 dissection for low rectal cancer: a comparison of dissections between the lateral pelvic lymph nodes and the lymph nodes along the root of the inferior mesenteric artery in a multicenter retrospective cohort study.
Inoue H; Sasaki K; Nozawa H; Kawai K; Murono K; Emoto S; Iida Y; Ishii H; Yokoyama Y; Anzai H; Sonoda H; Ozaki K; Yamauchi S; Sugihara K; Ishihara S
Int J Colorectal Dis; 2021 Jun; 36(6):1263-1270. PubMed ID: 33537876
[TBL] [Abstract][Full Text] [Related]
13. Effect of Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB-IMRT) and Non-Operative Strategy on Outcomes of Distal Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node.
Li S; Geng J; Wang L; Teng H; Wang Z; Zhu X; Zhang Y; Wang H; Li Y; Cai Y; Wu A; Wang W
Cancer Manag Res; 2021; 13():537-546. PubMed ID: 33519233
[TBL] [Abstract][Full Text] [Related]
14. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
[TBL] [Abstract][Full Text] [Related]
15. The Role of Concomitant Radiation Boost in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Badakhshi H; Ismail M; Boskos C; Zhao K; Kaul D
Anticancer Res; 2017 Jun; 37(6):3201-3205. PubMed ID: 28551665
[TBL] [Abstract][Full Text] [Related]
16. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
Mattiucci GC; Boldrini L; Nardangeli A; D'Aviero A; Buwenge M; Cellini F; Deodato F; Dinapoli N; Frascino V; Macchia G; Morganti AG; Valentini V
J Cancer Res Clin Oncol; 2021 Mar; 147(3):661-667. PubMed ID: 33001271
[TBL] [Abstract][Full Text] [Related]
18. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
Kim MJ; Hur BY; Lee ES; Park B; Joo J; Kim MJ; Park SC; Baek JY; Chang HJ; Kim DY; Oh JH
PLoS One; 2018; 13(4):e0195815. PubMed ID: 29649321
[TBL] [Abstract][Full Text] [Related]
19. Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging.
Otowa Y; Yamashita K; Kanemitsu K; Sumi Y; Yamamoto M; Kanaji S; Imanishi T; Nakamura T; Suzuki S; Tanaka K; Kakeji Y
Onco Targets Ther; 2015; 8():3169-73. PubMed ID: 26604786
[TBL] [Abstract][Full Text] [Related]
20. Concomitant dose escalation with image-guided Tomotherapy in locally advanced mid-low rectal cancer: a single-center study.
Zhao J; Liu X; Wang W; Hu K; Zhang F; Hou X; Meng Q
Cancer Manag Res; 2019; 11():1579-1586. PubMed ID: 30863168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
